Solicitation Amendment W81K0025QA1200001 SF 30.pdf

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers is extended. is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended, by one of the following methods:

(a) By completing items 8 and 15, and returning copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of theoffer submitted;

or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.

If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NUMBER AS DESCRIBED IN ITEM 14.

CHECK ONE A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER

NUMBER IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation data, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print) 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

15B. CONTRACTOR/OFFEROR

(Signature of person authorized to sign)

15C. DATE SIGNED 16B. UNITED STATES OF AMERICA

(Signature of Contracting Officer)

16C. DATE SIGNED

Previous edition unusable STANDARD FORM 30 (REV. 11/2016) Prescribed by GSA FAR (48 CFR) 53.243

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT 1. CONTRACT ID CODE PAGE OF PAGES

2. AMENDMENT/MODIFICATION NUMBER 3. EFFECTIVE DATE 4. REQUISITION/PURCHASE REQUISITION NUMBER 5. PROJECT NUMBER (If applicable)

6. ISSUED BY CODE 7. ADMINISTERED BY (If other than Item 6) CODE

8. NAME AND ADDRESS OF CONTRACTOR (Number, street, county, State and ZIP Code) (X) 9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED (SEE ITEM 11)

10A. MODIFICATION OF CONTRACT/ORDER NUMBE

10B. DATED (SEE ITEM 13)

CODE FACILITY CODE

J 1 5

0001 14 JUL 2025

W81K00

W40M MRC0 WEST

MEDICAL READINESS CONTR OFFICE WEST, 3160 MCINDOE BLDG1103

JBSA FT SAM HOUSTON, TX 78234-4504

UNITED STATES

KARAN QUILES, EMAIL: KARAN.E.QUILES.CIV@HEALTH.MIL TELEPHONE: KARAN.E.

QUILES.CIV@HEALTH.MIL

SCD: PAS:

W81K0025QA120

01 JUL 2025

SEE CONTINUATION

THIS AMENDMENT IS TWO FOLD: 1) UPDATE CLIN'S AA, AB AND AC FOR THE BASE AND ALL OPTION CLIN'S TO REFLECT ADEQUATE DESCRIPTION OF THIS SERVICE REQUIREMENT AND 2) UPDATE THE PERFORMANCE WORK STATEMENT TO REFLECT THE UPDATED VERBIAGE IN THE CLIN STRUCTURE.

JOSHUA P. BARBERO

14 JUL 2025

SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

Continuation of Supplies or Services and Prices/Costs

The following CLIN(s) / SLIN(s) / ELIN(s) were modified:

0001AA

INFORMATION FROM TO CHANGED

BY

Description

Whole Blood Test Panel- Blood Testing Standard which includes the following tests:

ABO/Rh, HBcA, Antibody screen, HCV, Antibody Identification, HIV 1 and 2, STS, HTLV 1 and 2, HBsAg, Chagas/ T. cruzi.

Whole Blood Test Panel-Blood Testing Standard which includes the following tests: HBsAg, ABO/Rh, Anti-HBc, Anti- HCV, Anti-HIIV 1/2, Anti-HTLV I/II, Syphilis (STS), Antibody Screen, HIV /HCV/HBV, NAT Ultrio (pooled), Babesia NAT (IDT), Chagas (T. cruzi), WNVNAT (IDT)

0001AB

INFORMATION FROM TO CHANGED

BY

Description Low Titer Whole Blood /Plasma Testing

Low Titer Whole Blood/Plasma Testing: Low Titer Whole Blood /Plasma Testing (ISO AGGLUTIN TITER aka Anti-A, B T)

0001AC

INFORMATION FROM TO CHANGED

BY

Description

Reference Lab Testing Nucleic Acid Test (NAT) panel shall include at a minimum: WNV NAT, HCV NAT, HBV NAT, HIV NAT , Babesia NAT

Reference Lab Testing: SARS-CoV-2 Ab (qualitative, Abbott), Ortho COVID assay (VITROS Anti-SARS-CoV-2 IgG), HLA Class I and HLA Class II Antibody Panel, Antibody Identification, Protein Electrophoresis

Option Line Item 1001AA

INFORMATION FROM TO CHANGED

BY

Description

Whole Blood Test Panel- Blood Testing Standard which includes the following tests:

ABO/Rh, HBcA, Antibody screen, HCV, Antibody Identification, HIV 1 and 2, STS, HTLV 1 and 2, HBsAg, Chagas/ T. cruzi.

Whole Blood Test Panel-Blood Testing Standard which includes the following tests: HBsAg, ABO/Rh, Anti-HBc, Anti- HCV, Anti-HIIV 1/2, Anti-HTLV I/II, Syphilis (STS), Antibody Screen, HIV /HCV/HBV, NAT Ultrio (pooled), Babesia NAT (IDT), Chagas (T. cruzi), WNVNAT (IDT)

Option Line Item 1001AB

INFORMATION FROM TO CHANGED

BY

Low Titer Low Titer Whole Blood/Plasma Testing: Low Titer

W81K0025QA1200001

Description Whole Blood /Plasma Testing

Whole Blood /Plasma Testing (ISO AGGLUTIN TITER aka Anti-A, B T)

Option Line Item 1001AC

INFORMATION FROM TO CHANGED

BY

Description

Reference Lab Testing Nucleic Acid Test (NAT) panel shall include at a minimum: WNV NAT, HCV NAT, HBV NAT, HIV NAT , Babesia NAT

Reference Lab Testing: SARS-CoV-2 Ab (qualitative, Abbott), Ortho COVID assay (VITROS Anti-SARS-CoV-2 IgG), HLA Class I and HLA Class II Antibody Panel, Antibody Identification, Protein Electrophoresis

Option Line Item 2001AA

INFORMATION FROM TO CHANGED

BY

Description

Whole Blood Test Panel- Blood Testing Standard which includes the following tests:

ABO/Rh, HBcA, Antibody screen, HCV, Antibody Identification, HIV 1 and 2, STS, HTLV 1 and 2, HBsAg, Chagas/ T. cruzi.

Whole Blood Test Panel-Blood Testing Standard which includes the following tests: HBsAg, ABO/Rh, Anti-HBc, Anti- HCV, Anti-HIIV 1/2, Anti-HTLV I/II, Syphilis (STS), Antibody Screen, HIV /HCV/HBV, NAT Ultrio (pooled), Babesia NAT (IDT), Chagas (T. cruzi), WNVNAT (IDT)

Option Line Item 2001AB

INFORMATION FROM TO CHANGED

BY

Description Low Titer Whole Blood /Plasma Testing

Low Titer Whole Blood/Plasma Testing: Low Titer Whole Blood /Plasma Testing (ISO AGGLUTIN TITER aka Anti-A, B T)

Option Line Item 2001AC

INFORMATION FROM TO CHANGED

BY

Description

Reference Lab Testing Nucleic Acid Test (NAT) panel shall include at a minimum: WNV NAT, HCV NAT, HBV NAT, HIV NAT , Babesia NAT

Reference Lab Testing: SARS-CoV-2 Ab (qualitative, Abbott), Ortho COVID assay (VITROS Anti-SARS-CoV-2 IgG), HLA Class I and HLA Class II Antibody Panel, Antibody Identification, Protein Electrophoresis

Option Line Item 3001AA

INFORMATION FROM TO CHANGED

BY

Description

Whole Blood Test Panel- Blood Testing Standard which includes the following tests:

ABO/Rh, HBcA, Antibody screen, HCV, Antibody Identification, HIV 1 and 2, STS, HTLV 1 and 2, HBsAg, Chagas/ T. cruzi.

Whole Blood Test Panel-Blood Testing Standard which includes the following tests: HBsAg, ABO/Rh, Anti-HBc, Anti- HCV, Anti-HIIV 1/2, Anti-HTLV I/II, Syphilis (STS), Antibody Screen, HIV /HCV/HBV, NAT Ultrio (pooled), Babesia NAT (IDT), Chagas (T. cruzi), WNVNAT (IDT)

Option Line Item 3001AB

CHANGED

INFORMATION FROM TO BY

Description Low Titer Whole Blood /Plasma Testing

Low Titer Whole Blood/Plasma Testing: Low Titer Whole Blood /Plasma Testing (ISO AGGLUTIN TITER aka Anti-A, B T)

Option Line Item 3001AC

INFORMATION FROM TO CHANGED

BY

Description

Reference Lab Testing Nucleic Acid Test (NAT) panel shall include at a minimum: WNV NAT, HCV NAT, HBV NAT, HIV NAT , Babesia NAT

Reference Lab Testing: SARS-CoV-2 Ab (qualitative, Abbott), Ortho COVID assay (VITROS Anti-SARS-CoV-2 IgG), HLA Class I and HLA Class II Antibody Panel, Antibody Identification, Protein Electrophoresis

Option Line Item 4001AA

INFORMATION FROM TO CHANGED

BY

Description

Whole Blood Test Panel- Blood Testing Standard which includes the following tests:

ABO/Rh, HBcA, Antibody screen, HCV, Antibody Identification, HIV 1 and 2, STS, HTLV 1 and 2, HBsAg, Chagas/ T. cruzi.

Whole Blood Test Panel-Blood Testing Standard which includes the following tests: HBsAg, ABO/Rh, Anti-HBc, Anti- HCV, Anti-HIIV 1/2, Anti-HTLV I/II, Syphilis (STS), Antibody Screen, HIV /HCV/HBV, NAT Ultrio (pooled), Babesia NAT (IDT), Chagas (T. cruzi), WNVNAT (IDT)

Option Line Item 4001AB

INFORMATION FROM TO CHANGED

BY

Description Low Titer Whole Blood /Plasma Testing

Low Titer Whole Blood/Plasma Testing: Low Titer Whole Blood /Plasma Testing (ISO AGGLUTIN TITER aka Anti-A, B T)

Option Line Item 4001AC

INFORMATION FROM TO CHANGED

BY

Description

Reference Lab Testing Nucleic Acid Test (NAT) panel shall include at a minimum: WNV NAT, HCV NAT, HBV NAT, HIV NAT , Babesia NAT

Reference Lab Testing: SARS-CoV-2 Ab (qualitative, Abbott), Ortho COVID assay (VITROS Anti-SARS-CoV-2 IgG), HLA Class I and HLA Class II Antibody Panel, Antibody Identification, Protein Electrophoresis

List of Contract Documents, Exhibits, or Attachments

The attachments table has changed from:

Identifier Document Name Document Description Reference Identifier Date Line Item Page

Numbers Document Type

Provided Under Separate Cover

PWS Infectious Blood Donor Testing

Performance Work Statement 01 Jul 2025 Attachment No

02 Solicitation Instructions Solicitation Instructions 01 Jul 2025 Attachment No

To:

Identifier Document Name Document Description Reference Identifier Date Line Item Page

Numbers Document Type

Provided Under Separate Cover

02 Solicitation Instructions Solicitation Instructions 01 Jul 2025 Attachment No

PWS Infectious Blood Donor Testing

Performance Work Statement 14 Jul 2025 Attachment No

The following contract documents were modified:

PWS Infectious Blood Donor Testing

INFORMATION FROM TO

Attachment Date 01 Jul 2025 14 Jul 2025 Attachment Identifier 01 03 Attachment URL 4246799 4546852